Dickinson Andrew D 4

What Happened Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), reported the sale of 3,000 shares on May 15, 2026. The shares were disposed at $132.27 each for total proceeds of approximately $396,810. The filing lists the disposition as an open market or private sale (code S).

Key Details

• Transaction date: 2026-05-15; Filing date: 2026-05-18 (Accession 0001310204-26-000016).
• Price: $132.27 per share; Shares sold: 3,000; Total value: ~$396,810.
• Transaction type/code: Sale (S) — open market or private sale.
• Footnote: Transaction executed pursuant to a Rule 10b5-1 trading plan adopted August 29, 2024.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: The Form 4 was filed three days after the transaction; the form does not indicate a late reporting designation.

Context A sale under a 10b5-1 plan means the trade was pre-scheduled under a plan established while the insider was not in possession of material nonpublic information. Such pre-set sales are common and often viewed as routine portfolio management rather than a direct signal about the company’s prospects. For retail investors, purchases typically carry more informational weight than routine, plan-driven sales.